Current drug targets

Keyphrases

Publications

2023

Kadirvel Devi, Thukani Sathanantham Shanmugarajan
Therapeutic Potential of Plant Metabolites in Bone Apoptosis: A Review. Current drug targets (2023)
Xinyue Zhai, Yuqian Wu, Huaping Tan
Gelatin-based Targeted Delivery Systems for Tissue Engineering. Current drug targets (2023)
Dharmendra Kumar, Nandan Sarkar, Kuldeep K Roy, Dheeraj Bisht, Deepak Kumar, Bitasta Mandal, Mogana R, Yadu Nandan Dey
The Potential of Mur Enzymes as Targets for Antimicrobial Drug Discovery. Current drug targets (2023)
Ibrahim Malami, Alhassan Alhassan, Adamu Adamu, Muhammad Bello, Aliyu Muhammad, Mustapha Imam
Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1α/VEGF signalling pathway. Current drug targets (2023)
Dilipkumar Pal, Padum Lal
Tropolones and Thailandepsin B as lead-like natural compounds in the development of potent and selective histone deacetylase inhibitors. Current drug targets (2023)
Mengmeng Chen, Jian Jiang, Junyu Chen, Mengqi Wang, Yaci Lu, Lei Liu, Lijing Zhao, Lisheng Wang
The clinical safety and efficacy of targeted PD-L1 therapy with durvalumab in solid tumors. Current drug targets (2023)
Aruna Rawat, Vikas Jhawat, Rohit Dutt
Nano Architect-Based Targeted Delivery Systems for Diabetic Nephropathy: A Review. Current drug targets (2023)
Erica Martins Ferreira Gotardo, Thaina Rodrigues de Morais, Ana Paula Timóteo Ferreira, Cintia Rabelo E Paiva Caria, Marcelo Lima Ribeiro, Alessandra Gambero
Deferoxamine interference in fibro-inflammation: additional action in control of obese adipose tissue dysfunction. Current drug targets (2023)
Mirtha Elisa Aguado, Maikel Izquierdo, Maikel González-Matos, Ana C Varela, Yanira Méndez, Maday Alonso Del Rivero, Daniel G Rivera, Jorge González-Bacerio
Parasite metalo-aminopeptidases as targets in human infectious diseases. Current drug targets (2023)
Sanket Kaushik
Differential drug permeability across Biofilms. Current drug targets (2023)
Jomon Sebastian, Krishnan Rathinasamy
Microtubules and Cell Division: Potential Pharmacological Targets in Cancer Therapy. Current drug targets (2023)
Jéssica Paiva de Moura, Érika Paiva de Moura Fernandes, Teresa Carolliny Moreira Lustoza Rodrigues, Alex France Messias Monteiro, Natália Ferreira de Sousa, Aline Matilde Ferreira Dos Santos, Marcus Tullius Scotti, Luciana Scotti
Targets Involved in Skin Aging and Photoaging and their Possible Inhibitors: A Mini-review. Current drug targets (2023)
Işil Var, Manaf AlMatar, Behzad Heshmati, Osman Albarri
Bacteriophage Cocktail Can Effectively Control Salmonella Biofilm on Gallstone and Tooth Surfaces. Current drug targets (2023)
Aliasgar F Shahiwala, Gazala A Khan
Potential Phytochemicals for Prevention of Familial Breast Cancer with BRCA Mutations. Current drug targets (2023)
Zhenyi Zhao, Jian Lv, Ningning Guo, Qiuxiao Guo, Sai Zeng, Yu Fang, Weixin Chen, Zhihua Wang
Dose-dependent effects of PRC2 and HDAC inhibitors on cardiomyocyte hypertrophy induced by phenylephrine. Current drug targets (2023)
Arzoo Pannu, Ramesh K Goyal
Serotonin and Depression: Scrutiny of New Targets for Future Anti-Depressant Drug Development. Current drug targets (2023)
Madhusmita Bhuyan, Malkiet Kaur, Udesh Kaushal, Manju Nagpal, Manjinder Singh, Geeta Aggarwal
Recent Avenues In Treatment Of Liver Diseases: Role Of Nanotechnology. Current drug targets (2023)
Vikrant Singh Rajput, Ashish Runthala, Inshad Ali Khan
Shikimate kinase inhibitors: An update on promising strategy against Mycobacterium tuberculosis. Current drug targets (2023)
Gleb Zyuz'kov
Targeted Regulation of Intracellular Signaling Transduction: A New Paradigm for Stimulation of Neurogenesis in Alzheimer's Disease. Current drug targets (2023)
Parnika M Sose, Gaurav Mahesh Doshi, Pravin P Kale
An Update on Autophagy as a Target in the Treatment of Alzheimer's Disease. Current drug targets (2023)
Ghazaleh Pourali, Zeinab Sadat Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A Ferns, Mohammad Ali Kiani, Amir Avan
Therapeutic Potential of Herbal medicine against Non-alcoholic Fatty Liver Disease. Current drug targets (2023)
Saumya Kapoor, Deep Rohan Chatterjee, Moumita Ghosh Chowdhury, Rudradip Das, Amit Shard
Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle. Current drug targets (2023)
Sau Har Lee, Chu Xin Ng, Sharon Rachel Wong, Pei Pei Chong
miRNAs overexpression and their role in breast cancer: Implications for cancer therapeutics. Current drug targets (2023)
Dilan Calisici, Serkan Yilmaz, Bayram Goktas
Toxic, Genotoxic and Teratogenic Effects of Ibuprofen and its Derivatives. Current drug targets (2023)
Zhiwei Yang, Xinhui Cai, Qiushi Ye, Yizhen Zhao, Xuhua Li, Shengli Zhang, Lei Zhang
High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior. Current drug targets (2023)
Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, Marcieli Fabris, Priscila Goes Camargo, Marcelle de Lima Ferreira Bispo
Proteasome as a Drug Target in Trypanosomatid Diseases. Current drug targets (2023)
Acharya Balkrishna, Rashmi Mittal, Vedpriya Arya
Unveiling Role of MicroRNAs in Metastasizing Triple Negative Breast Cancer: From Therapeutics to Delivery. Current drug targets (2023)
Aditay Kumar, Mahesh Kumar
Co-Crystallization: A Novel Technique to Improvise the Pharmaceutical Characteristics of API's. Current drug targets (2023)
Deepika Yadav, Pramod Kumar Sharma, Rishabha Malviya, Prem Shankar Mishra
Strategies for Treatment of Thyroid Cancer. Current drug targets (2023)
Haigang Cui, Xin Luo, Mingwei Chen, Jun Lu, Johnson J Liu
Investigational Agents Targeting SGLT1 and SGLT2 in the Treatment of Type 2 Diabetes Mellitus. Current drug targets (2023)
Dilpreet Singh, Neena Bedi, Pooja Chawla
Structural Modifications in Chitosan Polymer Carries Synergistic Transfection in Drug Targeting. Current drug targets (2023)
Anmol Kapoor, Chandi C Mandal
A Perspective on Bone Morphogenetic Proteins: Dilemma behind Cancer-related Responses. Current drug targets (2023)
Satakshi Hazra, Risha Hazarika, Sanjukta Patra
Multitargeting: An Alternative Approach to Tackling Multidrug Resistance Issues in Tuberculosis. Current drug targets (2023)
Sarmili Sahoo, Raj Kumar Narang, Amandeep Singh
The Marburg virus outbreak in West Africa. Current drug targets (2023)
Darshan Gevariya, Lipika Priya, Smit Mehta, Vishwas Patel, Dhara Bhuva, Drishti Panjwani, Shruti Patel, Priyanka Ahlawat, Abhay Dharamsi, Asha Patel
Bio-Functional Mesoporous Silica Nanoparticles as Nano-Structured Carriers in Cancer Theranostic Review on Recent Advancements. Current drug targets (2023)
Masoumeh Eliyasi Dashtaki, Zahra Moradi, Yousef Moradi, Elham Asadi, Sorayya Ghasemi
Estimating the survival rate in glioblastoma multiforme patients who received a peptide vaccine: a systematic review and meta-analysis. Current drug targets (2023)
Boniface Kamdem Pone, Fabrice Fekam Boyom
Current Prospects of Saponins as Promising Anti-Trypanosoma Brucei Compounds: Insight into the Mechanisms of Action. Current drug targets (2023)
Sowmya Chivukula, Vasavi Malkhed
The Role of CDK20 Protein in Carcinogenesis. Current drug targets (2023)
Farveh Yahyapoor, Neda Haghighat, Zahra Sohrabi, Omid Asbaghi, Mohammad Bagherniya, Tannaz Jamialahmadi, Amirhossein Sahebkar
Effects of Kefir Consumption on Cardiometabolic Risk Factors: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current drug targets (2023)

volume 24, number 2, 2023

Janay Stefany Carneiro Araújo, Larissa de Mattos Oliveira, Kaio Vinícius Freitas de Andrade, Raquel Guimarães Benevides, Franco Henrique Andrade Leite, Manoelito Coelho Dos Santos Junior
Superoxide Dismutase Inhibitors against Malaria, Leishmaniasis, and Chagas Disease: Systematic Review. Current drug targets 24 (2) (2023)
Janay Stefany Carneiro Araújo, Larissa de Mattos Oliveira, Kaio Vinícius Freitas de Andrade, Raquel Guimarães Benevides, Franco Henrique Andrade Leite, Manoelito Coelho Dos Santos Junior
Superoxide Dismutase Inhibitors against Malaria, Leishmaniasis, and Chagas Disease: Systematic Review. Current drug targets 24 (2) (2023)

volume 24, number 3, 2023

Ashish Patel, Drashti Shah, Yug Patel, Stuti Patel, Meshwa Mehta, Tushar Bambharoliya
A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease. Current drug targets 24 (3) (2023)
Daniela Pacheco Dos Santos Haupenthal, Marcus Barg Resmini, Leandro Almeida Da Silva, Mateus Cardoso Colares, Laura de Roch Casagrande, Ligia Milanez Venturini, Thiago Antônio Moretti de Andrade, Fernando Russo Costa do Bomfim, Anand Thirupathi, Paulo Emilio Feuser, Felipe Dal Pizzol, Paulo Cesar Lock Silveira
Intra-articular Treatment with Triamcinolone Hexacetonide Associated with Gold Nanoparticles Reduces Cartilage Degeneration in an Animal Model of Osteoarthritis. Current drug targets 24 (3) (2023)
Priya Bisht, Neha Dagar, Nitesh Kumar, Ravichandiran Velayutham, Somasundaram Arumugam
Potential Targets in Constipation Research: A Review. Current drug targets 24 (3) (2023)
Ashish Patel, Drashti Shah, Yug Patel, Stuti Patel, Meshwa Mehta, Tushar Bambharoliya
A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease. Current drug targets 24 (3) (2023)
Priya Bisht, Neha Dagar, Nitesh Kumar, Ravichandiran Velayutham, Somasundaram Arumugam
Potential Targets in Constipation Research: A Review. Current drug targets 24 (3) (2023)
Daniela Pacheco Dos Santos Haupenthal, Marcus Barg Resmini, Leandro Almeida Da Silva, Mateus Cardoso Colares, Laura de Roch Casagrande, Ligia Milanez Venturini, Thiago Antônio Moretti de Andrade, Fernando Russo Costa do Bomfim, Anand Thirupathi, Paulo Emilio Feuser, Felipe Dal Pizzol, Paulo Cesar Lock Silveira
Intra-articular Treatment with Triamcinolone Hexacetonide Associated with Gold Nanoparticles Reduces Cartilage Degeneration in an Animal Model of Osteoarthritis. Current drug targets 24 (3) (2023)
Jitendra Gupta, Reena Gupta
A Scoping New Revolution for Tinnitus Management: A Neuromonics Narrative Review. Current drug targets 24 (3) (2023)
Jitendra Gupta, Reena Gupta
A Scoping New Revolution for Tinnitus Management: A Neuromonics Narrative Review. Current drug targets 24 (3) (2023)

volume 24, number 9, 2023

Dilipkumar Pal
Histone Deacetylase (HDAC) Inhibitors: A Fruitful Lead for Medicinal Chemists in the Discovery of Novel Drug(s) for Various Health Disorders. Current drug targets 24 (9) (2023)